Baricitinib trifluoroacetate
- CAS1187594-10-0
- CatalogueRS-Z001RVV
- FormulaC18H18F3N7O4S
- MW485.11
BACK ORDER
On this page
Product identification
| Product name | Baricitinib trifluoroacetate |
|---|---|
| Catalogue No. | RS-Z001RVV |
| CAS No. | 1187594-10-0 |
| Molecular formula | C18H18F3N7O4S |
| Molecular weight | 485.11 |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Chemical Reagents |
| Drug substance | Baricitinib |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-Z001RVV / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-Z001RVV and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Baricitinib
- Chemical Reagents of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-Z001RVV
- Request a quotation for RS-Z001RVV
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Baricitinib
All 127 further standards are listed here — every link is in the page, not loaded later.
-
Baricitinib
IN STOCKRS-I012012 -
Baricitinib Impurity A
IN STOCKRS-B011008 -
Baricitinib Impurity G
IN STOCKRS-B011025 -
Baricitinib Impurity I
IN STOCKRS-B011024 -
(1H-Pyrazol-4-yl)boronic acid hydrochloride
IN STOCKRS-U015350 -
(1H-Pyrazol-5-yl)boronic acid
IN STOCKRS-Z409VM9 -
1-Boc-3-hydroxyazetidine
IN STOCKRS-U005597 -
1-Boc-4-bromopyrazole
IN STOCKRS-U005858 -
1-Boc-4-iodopyrazole
IN STOCKRS-I012308 -
1-methylcyclobutane-1-carbaldehyde
IN STOCKRS-U010A96 -
1H-Pyrazol-4-ylboronic acid
IN STOCKRS-C007060 -
2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimidine
CUSTOM SYNTHESISRS-U083415 -
2-(3-Chloro-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile
IN STOCKRS-I516232 -
2-(3-Chloroazetidin-3-yl)acetonitrile
IN STOCKRS-U096408 -
2-(Azetidin-3-ylidene)acetic acid
CUSTOM SYNTHESISRS-Z401KUZ -
2-(Azetidin-3-ylidene)acetonitrile 4-methylbenzenesulfonic acid
CUSTOM SYNTHESISRS-Z406210 -
2-(trimethylsilyl)ethoxymethyl chloride
IN STOCKRS-U083333 -
2-{1-[(tert-butoxy)carbonyl]azetidin-3-yl}-2-hydroxyacetic acid
BACK ORDERRS-U016779 -
3-amino-1-(azepan-1-yl)propan-1-one
BACK ORDERRS-U056790 -
5-Chloro-7H-pyrrolo[2,3-d]pyrimidine
CUSTOM SYNTHESISRS-U211LE9 -
6-Chloro-7H-pyrrolo[2,3-d]pyrimidine
IN STOCKRS-U211OXD -
7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-ol
IN STOCKRS-B011218 -
7-Deazahypoxanthine
IN STOCKRS-C002089 -
Baricitinib d5
IN STOCKRS-B011076 -
Baricitinib Impurity IV
IN STOCKRS-B011006 -
Baricitinib Impurity VII
IN STOCKRS-B011007 -
Baricitinib Sulfonyl Impurity
IN STOCKRS-B011004 -
Baricitinib-D3
IN STOCKRS-B011087 -
Baricitinib-D4 (azetidine-2,2-d2)(Ethyl-1,1-d2)
IN STOCKRS-B011064 -
Ethyl 2-Cyano-4,4-diethoxybutyrate
IN STOCKRS-U095265 -
Formamidine Acetate
IN STOCKRS-A012047 -
Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate
IN STOCKRS-P140005 -
Methyl Ethanesulfonate
IN STOCKRS-C001039 -
N-7-Hydroxymethyl Baricitinib
IN STOCKRS-B011009 -
tert-Butyl 2-chloro-5H-pyrrolo[3,2-d]pyrimidine-5-carboxylate
IN STOCKRS-P010550 -
tert-Butyl 2-chloro-7,8-dihydropyrido[3,2-d]pyrimidine-5(6H)-carboxylate
IN STOCKRS-P010188 -
64
IN STOCKRS-Z401FM8 -
Baricitinib Impurity 2 Hydrochloride
IN STOCKRS-B011065 -
Baricitinib Impurity 14
IN STOCKRS-B011030 -
Baricitinib Impurity 16 (2HCl Salt)
IN STOCKRS-B011043 -
Baricitinib Impurity 19
IN STOCKRS-B011054 -
Baricitinib Impurity 20 HCl
CUSTOM SYNTHESISRS-B011019 -
Baricitinib Impurity 25 HCl
IN STOCKRS-B011069 -
Baricitinib Impurity 26
IN STOCKRS-B011003 -
Baricitinib Impurity 27
IN STOCKRS-B011056 -
Baricitinib Impurity 28
CUSTOM SYNTHESISRS-I001BVA -
Baricitinib Impurity 28 Hydrochloride
IN STOCKRS-B011037 -
Baricitinib Impurity 33
CUSTOM SYNTHESISRS-Z401IXQ -
Baricitinib Impurity 47
BACK ORDERRS-I001A1Y -
Baricitinib Impurity 69
IN STOCKRS-I001A13 -
Baricitinib Impurity 76 Sodium Salt
IN STOCKRS-B011071 -
Baricitinib Impurity 96
IN STOCKRS-I001AA0 -
Baricitinib Impurity 97
IN STOCKRS-I001781 -
Baricitinib Impurity 101
IN STOCKRS-B011012 -
Baricitinib Impurity 102
BACK ORDERRS-I001A71 -
Baricitinib Impurity 117
BACK ORDERRS-I001AUY -
Baricitinib Impurity 119
IN STOCKRS-Z394EBC -
Baricitinib Impurity 120
BACK ORDERRS-I001AMP -
Baricitinib Impurity 140
IN STOCKRS-B011074 -
Baricitinib Impurity 140
BACK ORDERRS-I001BJK -
Baricitinib Impurity 142
BACK ORDERRS-I001BJL -
Baricitinib Impurity 191
IN STOCKRS-B011001 -
Baricitinib Impurity 192
IN STOCKRS-B011026 -
Baricitinib Impurity 193
IN STOCKRS-B011028 -
Baricitinib Impurity 194
IN STOCKRS-B011031 -
Baricitinib Impurity 195
CUSTOM SYNTHESISRS-B011035 -
Baricitinib Impurity 196
IN STOCKRS-B011046 -
Baricitinib Impurity 197
IN STOCKRS-B011058 -
Baricitinib Impurity 198
IN STOCKRS-B011059 -
Baricitinib Impurity 199
IN STOCKRS-B011060 -
Baricitinib Impurity 200
IN STOCKRS-B011063 -
Baricitinib Impurity 201
IN STOCKRS-B011066 -
Baricitinib Impurity 202
CUSTOM SYNTHESISRS-B011068 -
Baricitinib Impurity 203
BACK ORDERRS-B011072 -
Baricitinib Impurity 204
IN STOCKRS-B011073 -
Baricitinib Impurity 205
IN STOCKRS-B011075 -
Baricitinib Impurity 216
IN STOCKRS-I012070 -
Baricitinib Impurity 217
IN STOCKRS-B011002 -
Baricitinib Impurity 218
IN STOCKRS-B011005 -
Baricitinib Impurity 219
IN STOCKRS-B011010 -
Baricitinib Impurity 220
IN STOCKRS-B011011 -
Baricitinib Impurity 221
IN STOCKRS-B011013 -
Baricitinib Impurity 222
IN STOCKRS-B011015 -
Baricitinib Impurity 223
IN STOCKRS-B011016 -
Baricitinib Impurity 224
IN STOCKRS-B011017 -
Baricitinib Impurity 225
IN STOCKRS-B011018 -
Baricitinib Impurity 226
IN STOCKRS-B011020 -
Baricitinib Impurity 227
IN STOCKRS-B011021 -
Baricitinib Impurity 228
IN STOCKRS-B011022 -
Baricitinib Impurity 229
IN STOCKRS-B011023 -
Baricitinib Impurity 230
IN STOCKRS-B011027 -
Baricitinib Impurity 231
IN STOCKRS-B011029 -
Baricitinib Impurity 232
IN STOCKRS-B011032 -
Baricitinib Impurity 233
IN STOCKRS-B011033 -
Baricitinib Impurity 234
IN STOCKRS-B011034 -
Baricitinib Impurity 235
CUSTOM SYNTHESISRS-B011036 -
Baricitinib Impurity 236
IN STOCKRS-B011038 -
Baricitinib Impurity 237
IN STOCKRS-B011039 -
Baricitinib Impurity 238
IN STOCKRS-B011040 -
Baricitinib Impurity 239
CUSTOM SYNTHESISRS-B011041 -
Baricitinib Impurity 240
IN STOCKRS-B011042 -
Baricitinib Impurity 241
IN STOCKRS-B011044 -
Baricitinib Impurity 242
IN STOCKRS-B011045 -
Baricitinib Impurity 243
IN STOCKRS-B011047 -
Baricitinib Impurity 244
IN STOCKRS-B011048 -
Baricitinib Impurity 245
IN STOCKRS-B011049 -
Baricitinib Impurity 246
IN STOCKRS-B011050 -
Baricitinib Impurity 247
IN STOCKRS-B011051 -
Baricitinib Impurity 248
IN STOCKRS-B011052 -
Baricitinib Impurity 249
IN STOCKRS-B011053 -
Baricitinib Impurity 250
IN STOCKRS-B011055 -
Baricitinib Impurity 251
IN STOCKRS-B011057 -
Baricitinib Impurity 252
CUSTOM SYNTHESISRS-B011061 -
Baricitinib Impurity 253
CUSTOM SYNTHESISRS-B011062 -
Baricitinib Impurity 254
CUSTOM SYNTHESISRS-B011070 -
Baricitinib Impurity 255
CUSTOM SYNTHESISRS-B011079 -
Baricitinib Impurity 256
CUSTOM SYNTHESISRS-B011080 -
Baricitinib Impurity 257
IN STOCKRS-B011081 -
Baricitinib Impurity 357
IN STOCKRS-U005071 -
Baricitinib Impurity 358
CUSTOM SYNTHESISRS-B011077 -
Baricitinib Impurity 359
IN STOCKRS-B011078 -
Baricitinib Impurity 360
IN STOCKRS-B011088
![Chemical structure of (4-(1-(3-(Cyanomethyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl Pivalate](/structures/w4/WYPSYJDXVKDEHX-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 2,4,5-Trichloro-7H-pyrrolo[2,3-d]pyrimidine](/structures/w4/YUKWSCQSOXCSES-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile phosphate](/structures/w4/FBPOWTFFUBBKBB-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 2-(3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile Dihydrochloride](/structures/w4/OJFGPWMRGJSJAO-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 2-{1-[(tert-butoxy)carbonyl]azetidin-3-yl}-2-hydroxyacetic acid](/structures/w4/XGHUUJMOUYDGKH-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 5-Chloro-7H-pyrrolo[2,3-d]pyrimidine](/structures/w4/LRBDMVYIUGZSKX-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 6-Chloro-7H-pyrrolo[2,3-d]pyrimidine](/structures/w4/VQAOTRGDQKVOPP-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-ol](/structures/w4/ZSRMCCBQIPDBNM-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate](/structures/w4/OVLUFZHAPSKJJO-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of tert-Butyl 2-chloro-5H-pyrrolo[3,2-d]pyrimidine-5-carboxylate](/structures/w4/UMQCAOWZQMWJFY-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of tert-Butyl 2-chloro-7,8-dihydropyrido[3,2-d]pyrimidine-5(6H)-carboxylate](/structures/w4/NIVWSHYBKCXEMR-UHFFFAOYSA-N.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.